<!doctype html>
<!--
  Minimal Mistakes Jekyll Theme 4.24.0 by Michael Rose
  Copyright 2013-2020 Michael Rose - mademistakes.com | @mmistakes
  Free for personal and commercial use under the MIT license
  https://github.com/mmistakes/minimal-mistakes/blob/master/LICENSE
-->
<html lang="en" class="no-js">
  <head>
    <meta charset="utf-8">

<!-- begin _includes/seo.html --><title>Indicator: 3.b.1 - SDG Metadata Translation Project</title>
<meta name="description" content="Machine Translation of Indicator Metadata for the Sustainable Development Goals">



<meta property="og:type" content="website">
<meta property="og:locale" content="en_US">
<meta property="og:site_name" content="SDG Metadata Translation Project">
<meta property="og:title" content="Indicator: 3.b.1">
<meta property="og:url" content="/sdg-metadata/metadata/en/3-b-1/">


  <meta property="og:description" content="Machine Translation of Indicator Metadata for the Sustainable Development Goals">












<link rel="canonical" href="/sdg-metadata/metadata/en/3-b-1/">




<script type="application/ld+json">
  {
    "@context": "https://schema.org",
    
      "@type": "Person",
      "name": null,
      "url": "/sdg-metadata/"
    
  }
</script>







<!-- end _includes/seo.html -->



  <link href="/sdg-metadata/feed.xml" type="application/atom+xml" rel="alternate" title="SDG Metadata Translation Project Feed">


<!-- https://t.co/dKP3o1e -->
<meta name="viewport" content="width=device-width, initial-scale=1.0">

<script>
  document.documentElement.className = document.documentElement.className.replace(/\bno-js\b/g, '') + ' js ';
</script>

<!-- For all browsers -->
<link rel="stylesheet" href="/sdg-metadata/assets/css/main.css">
<link rel="preload" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@5/css/all.min.css" as="style" onload="this.onload=null;this.rel='stylesheet'">
<noscript><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@5/css/all.min.css"></noscript>



    <!-- Favicons -->
<link rel="shortcut icon" type="image/ico" href="/sdg-metadata/assets/img/favicons/favicon.ico">
<link rel="icon" type="image/png" href="/sdg-metadata/assets/img/favicons/favicon.png">
<!-- Mathjax -->
<script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>

<!-- Global site tag (gtag.js) - Google Analytics -->
<script async src="https://www.googletagmanager.com/gtag/js?id=G-7NJNVVD13B"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-7NJNVVD13B');
</script>

<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/jquery.tablesorter/2.31.3/css/theme.blue.min.css" integrity="sha512-jJ9r3lTLaH5XXa9ZOsCQU8kLvxdAVzyTWO/pnzdZrshJQfnw1oevJFpoyCDr7K1lqt1hUgqoxA5e2PctVtlSTg==" crossorigin="anonymous" referrerpolicy="no-referrer" />

  </head>

  <body class="layout--indicator language-en">
    <nav class="skip-links">
  <ul>
    <li><a href="#site-nav" class="screen-reader-shortcut">Skip to primary navigation</a></li>
    <li><a href="#main" class="screen-reader-shortcut">Skip to content</a></li>
    <li><a href="#footer" class="screen-reader-shortcut">Skip to footer</a></li>
  </ul>
</nav>

    <!--[if lt IE 9]>
<div class="notice--danger align-center" style="margin: 0;">You are using an <strong>outdated</strong> browser. Please <a href="https://browsehappy.com/">upgrade your browser</a> to improve your experience.</div>
<![endif]-->

    



<div class="masthead">
  <div class="masthead__inner-wrap">
    <div class="masthead__menu">
      <nav id="site-nav" class="greedy-nav">
        
        <a class="site-title" href="/sdg-metadata/">
          SDG Metadata Translation Project
          <span class="site-subtitle">Machine Translation of Indicator Metadata for the Sustainable Development Goals</span>
        </a>

        

        
        <button class="greedy-nav__toggle hidden" type="button">
          <span class="visually-hidden">Toggle menu</span>
          <div class="navicon"></div>
        </button>
        <ul class="hidden-links hidden"></ul>
      </nav>
    </div>

    <div class="worldbank-logo">
  <img
    src="/sdg-metadata/assets/img/WBG_Horizontal-RGB-web.png"
    alt="World Bank logo"
  />
</div>

  </div>
</div>


    <div class="initial-content">
      



<div id="main" role="main">
  
  <div class="sidebar sticky">
  
  
    
      
      <h3>SDMX Metadata Concepts</h3>
      <ul class="indicator-fields"><li><a href="#SDG_GOAL">0.a. Goal</a></li><li><a href="#SDG_TARGET">0.b. Target</a></li><li><a href="#SDG_INDICATOR">0.c. Indicator</a></li><li><a href="#META_LAST_UPDATE">0.e. Metadata update</a></li><li><a href="#SDG_RELATED_INDICATORS">0.f. Related indicators</a></li><li><a href="#SDG_CUSTODIAN_AGENCIES">0.g. International organisations(s) responsible for global monitoring</a></li><li><a href="#CONTACT_ORGANISATION">1.a. Organisation</a></li><li><a href="#STAT_CONC_DEF">2.a. Definition and concepts</a></li><li><a href="#UNIT_MEASURE">2.b. Unit of measure</a></li><li><a href="#SOURCE_TYPE">3.a. Data sources</a></li><li><a href="#COLL_METHOD">3.b. Data collection method</a></li><li><a href="#FREQ_COLL">3.c. Data collection calendar</a></li><li><a href="#REL_CAL_POLICY">3.d. Data release calendar</a></li><li><a href="#DATA_SOURCE">3.e. Data providers</a></li><li><a href="#COMPILING_ORG">3.f. Data compilers</a></li><li><a href="#RATIONALE">4.a. Rationale</a></li><li><a href="#REC_USE_LIM">4.b. Comment and limitations</a></li><li><a href="#DATA_COMP">4.c. Method of computation</a></li><li><a href="#DATA_VALIDATION">4.d. Validation</a></li><li><a href="#ADJUSTMENT">4.e. Adjustments</a></li><li><a href="#IMPUTATION">4.f. Treatment of missing values (i) at country level and (ii) at regional level</a></li><li><a href="#REG_AGG">4.g. Regional aggregations</a></li><li><a href="#DOC_METHOD">4.h. Methods and guidance available to countries for the compilation of the data at the national level</a></li><li><a href="#QUALITY_MGMNT">4.i. Quality management</a></li><li><a href="#QUALITY_ASSURE">4.j. Quality assurance</a></li><li><a href="#QUALITY_ASSMNT">4.k. Quality assessment</a></li><li><a href="#COVERAGE">5. Data availability and disaggregation</a></li><li><a href="#COMPARABILITY">6. Comparability/deviation from international standards</a></li><li><a href="#OTHER_DOC">7. References and Documentation</a></li></ul>

      
    
    
  
  </div>



  <article class="page" itemscope itemtype="https://schema.org/CreativeWork">
    <meta itemprop="headline" content="Indicator: 3.b.1">
    
    
    

    <div class="page__inner-wrap">
      
        <header>
          <h1 id="page-title" class="page__title" itemprop="headline">Indicator: 3.b.1
</h1>
          


        </header>
      

      <section class="page__content" itemprop="text">
        
        <div class="download-buttons">
  <a class="btn btn--info" href="/sdg-metadata/documents/en/3-b-1.pdf">Download PDF</a>
</div>

<a name="SDG_GOAL"></a><div id="SDG_GOAL"><p class="concept-name">0.a. Goal</p><p>Goal 3: Ensure healthy lives and promote well-being for all at all ages</p></div><a name="SDG_TARGET"></a><div id="SDG_TARGET"><p class="concept-name">0.b. Target</p><p>Target 3.b: Support the research and development of vaccines and medicines for the communicable and non&#x2011;communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all</p></div><a name="SDG_INDICATOR"></a><div id="SDG_INDICATOR"><p class="concept-name">0.c. Indicator</p><p>Indicator 3.b.1: Proportion of the target population covered by all vaccines included in their national programme </p></div><a name="META_LAST_UPDATE"></a><div id="META_LAST_UPDATE"><p class="concept-name">0.e. Metadata update</p>2023-03-31</div><a name="SDG_RELATED_INDICATORS"></a><div id="SDG_RELATED_INDICATORS"><p class="concept-name">0.f. Related indicators</p><p>Target 3.8 Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all. Indicator 3.8.1: Coverage of essential health services (defined as the average coverage of essential services based on tracer interventions that include reproductive, maternal, newborn and child health, infectious diseases, non-communicable diseases and service capacity and access, among the general and the most disadvantaged population) </p></div><a name="SDG_CUSTODIAN_AGENCIES"></a><div id="SDG_CUSTODIAN_AGENCIES"><p class="concept-name">0.g. International organisations(s) responsible for global monitoring</p><p>World Health Organization (WHO), United Nations Children&#x2019;s Fund (UNICEF) </p></div><a name="CONTACT_ORGANISATION"></a><div id="CONTACT_ORGANISATION"><p class="concept-name">1.a. Organisation</p><p>World Health Organization (WHO), United Nations Children&#x2019;s Fund (UNICEF) </p></div><a name="STAT_CONC_DEF"></a><div id="STAT_CONC_DEF"><p class="concept-name">2.a. Definition and concepts</p><p><strong>Definition:</strong> </p>
<p><em>Coverage of DTP containing vaccine (3<sup>rd</sup> dose):</em> Percentage of surviving infants who received the 3 doses of diphtheria and tetanus toxoid with pertussis containing vaccine in a given year. </p>
<p> </p>
<p>Coverage of Measles containing vaccine (2<sup>nd</sup> dose): Percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year. </p>
<p> </p>
<p>Coverage of Pneumococcal conjugate vaccine (last dose in the schedule): Percentage of surviving infants who received the nationally recommended doses of pneumococcal conjugate vaccine in a given year. </p>
<p> </p>
<p>Coverage of HPV vaccine (last dose in the schedule):<strong> </strong>Percentage of 15 years old girls who received the recommended doses of HPV vaccine. Currently performance of the programme in the previous calendar year based on target age group is used. </p>
<p> </p>
<p><strong>Concepts:</strong> </p>
<p>In accordance with its mandate to provide guidance to Member States on health policy matters, WHO provides global vaccine and immunization recommendations for diseases that have an international public health impact. National programmes adapt the recommendations and develop national immunization schedules, based on local disease epidemiology and national health priorities. National immunization schedules and number of recommended vaccines vary between countries, with only DTP polio and measles containing vaccines being used in all countries. </p>
<p> </p>
<p>The target population for given vaccine is defined based on recommended age for administration. The primary vaccination series of most vaccines are administered in the first two years of life. </p>
<p> </p>
<p><em>Coverage of DTP containing vaccine</em> measure the overall system strength to deliver infant vaccination </p>
<p>Coverage of Measles containing vaccine ability to deliver vaccines beyond first year of life through routine immunization services. </p>
<p>Coverage of Pneumococcal conjugate vaccine: adaptation of new vaccines for children </p>
<p>Coverage of HPV vaccine: life course vaccination<strong> </strong> </p>
<p> </p></div><a name="UNIT_MEASURE"></a><div id="UNIT_MEASURE"><p class="concept-name">2.b. Unit of measure</p><p>Percent</p></div><a name="SOURCE_TYPE"></a><div id="SOURCE_TYPE"><p class="concept-name">3.a. Data sources</p><p>National Health Information Systems or National Immunization systems </p>
<p>National immunization registries </p>
<p>High quality household surveys with immunization module (e.g. Demographic and Health Surveys (DHS), Multiple-Indicator Health Surveys (MICS), other national surveys) </p></div><a name="COLL_METHOD"></a><div id="COLL_METHOD"><p class="concept-name">3.b. Data collection method</p><p>Annual data collection through established mechanism. Since 1998, in an effort to strengthen collaboration and minimize the reporting burden, WHO and UNICEF jointly collect information through a standard questionnaire (the Joint Reporting Form) sent to all Member States <a href="http://www.who.int/immunization/monitoring_surveillance/routine/reporting/en/" target="_blank"><u>http://www.who.int/immunization/monitoring_surveillance/routine/reporting/en/</u></a> </p></div><a name="FREQ_COLL"></a><div id="FREQ_COLL"><p class="concept-name">3.c. Data collection calendar</p><p>Annual data collection March-May each year. Country consultation June each year </p></div><a name="REL_CAL_POLICY"></a><div id="REL_CAL_POLICY"><p class="concept-name">3.d. Data release calendar</p><p>15 July each year for time series 1980 &#x2013; release year -1. (on 17 July 2023 estimates from 1980-2022) </p></div><a name="DATA_SOURCE"></a><div id="DATA_SOURCE"><p class="concept-name">3.e. Data providers</p><p>Ministries of Health, Immunization programmes, DHS and MICS websites </p></div><a name="COMPILING_ORG"></a><div id="COMPILING_ORG"><p class="concept-name">3.f. Data compilers</p><p>WHO and UNICEF</p></div><a name="RATIONALE"></a><div id="RATIONALE"><p class="concept-name">4.a. Rationale</p><p>This indicator aims to measure access to vaccines, including the newly available or underutilized vaccines, at the national level. In the past decades all countries added numerous new and underutilised vaccines in their national immunization schedule and there are several vaccines under final stage of development to be introduced by 2030. For monitoring diseases control and impact of vaccines it is important to measure coverage from each vaccine in national immunization schedule. A system is already in place to monitor immunization coverage for all national programmes, however direct measurement for proportion of population covered with all vaccines in the programme is only feasible if the country has a well-functioning national electronic immunization registry allowing coverage by cohort to be easily estimated. While countries will develop and strengthen immunization registries there is a need for an alternative measurement.</p></div><a name="REC_USE_LIM"></a><div id="REC_USE_LIM"><p class="concept-name">4.b. Comment and limitations</p><p>The rational to select a set of vaccines reflects the ability of immunization programmes to deliver vaccines over the life cycle and to adapt new vaccines. Coverage for other WHO recommended vaccines are also available and can be provided. </p>
<p> </p>
<p>Given that HPV vaccine is relatively new and vaccination schedule varies from countries to country coverage estimate will be made for girls vaccinated by ag 15 and at the moment data is limited to very few countries therefore reporting will start later. </p></div><a name="DATA_COMP"></a><div id="DATA_COMP"><p class="concept-name">4.c. Method of computation</p><p>WHO and UNICEF jointly developed a methodology to estimate national immunization coverage form selected vaccines in 2000, and this approach has been refined and reviewed by expert committees over time. The methodology was published and reference is available under the reference section. Estimates time series for WHO recommended vaccines produced and published annually since 2001. </p>
<p>The methodology uses data reported by national authorities from countries administrative systems as well as data from immunization or multi indicator household surveys. The WHO/UNICEF estimates of national immunization coverage have been assessed using the Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) checklist. </p></div><a name="DATA_VALIDATION"></a><div id="DATA_VALIDATION"><p class="concept-name">4.d. Validation</p><p>WHO and UNICEF encourage countries to review and comment on the draft coverage estimates shared following the draft production. In past years, regional or sub-regional consultations have been held during May/June to go through select country data and estimates. </p></div><a name="ADJUSTMENT"></a><div id="ADJUSTMENT"><p class="concept-name">4.e. Adjustments</p><p>Not applicable</p></div><a name="IMPUTATION"></a><div id="IMPUTATION"><p class="concept-name">4.f. Treatment of missing values (i) at country level and (ii) at regional level</p><ul>
  <li><strong>At country level </strong></li>
</ul>
<p>The first data point is the first reporting year after vaccine introduction. When country data are not available interpolation is used between 2 data points and extrapolation from the latest available data point. </p>
<ul>
  <li><strong>At regional and global levels </strong></li>
</ul>
<p>Any needed imputation is done at country level. These country values are then used to compute regional and global estimates. </p></div><a name="REG_AGG"></a><div id="REG_AGG"><p class="concept-name">4.g. Regional aggregations</p><p>Weighted average of the country-level coverage rates where the weights are the country target population sizes based on World Population Prospects: 2022 revision from the UN Population Division. All Member States from the region are included. For HPV 15 year old girls are used for calculation weighted average. </p></div><a name="DOC_METHOD"></a><div id="DOC_METHOD"><p class="concept-name">4.h. Methods and guidance available to countries for the compilation of the data at the national level</p><p>Not applicable</p></div><a name="QUALITY_MGMNT"></a><div id="QUALITY_MGMNT"><p class="concept-name">4.i. Quality management</p><p>Not applicable</p></div><a name="QUALITY_ASSURE"></a><div id="QUALITY_ASSURE"><p class="concept-name">4.j. Quality assurance</p><p>Not applicable</p></div><a name="QUALITY_ASSMNT"></a><div id="QUALITY_ASSMNT"><p class="concept-name">4.k. Quality assessment</p><p>Not applicable</p></div><a name="COVERAGE"></a><div id="COVERAGE"><p class="concept-name">5. Data availability and disaggregation</p><p><strong>Data availability:</strong></p>
<p>Coverage data for different vaccines are collected annually and reviewed by WHO and UNICEF inter agency expert group and estimates made for each country and each year. Data are published both on WHO and UNICEF web sites. </p>
<p><a href="http://www.who.int/immunization/%20monitoring_surveillance/routine/coverage/en/index4.html" target="_blank"><u>http://www.who.int/immunization/ monitoring_surveillance/routine/coverage/en/index4.html</u></a><u> </u><a href="http://www.data.unicef.org/child-health/immunization" target="_blank"><u>http://www.data.unicef.org/child-health/immunization</u></a> </p>
<p> </p>
<p>Coverage for 2021 (in %)</p>
<table>
  <tbody>
    <tr>
      <td>
        <p> </p>
      </td>
      <td>
        <p>DTP3 </p>
      </td>
      <td>
        <p>MCV2 </p>
      </td>
      <td>
        <p>PCV3 </p>
      </td>
      <td>
        <p>HPV </p>
      </td>
    </tr>
    <tr>
      <td>
        <p>Global </p>
      </td>
      <td>
        <p>81</p>
      </td>
      <td>
        <p>71</p>
      </td>
      <td>
        <p>51</p>
      </td>
      <td>
        <p>12</p>
      </td>
    </tr>
    <tr>
      <td>
        <p>Australia and New Zealand </p>
      </td>
      <td>
        <p>94</p>
      </td>
      <td>
        <p>92</p>
      </td>
      <td>
        <p>96</p>
      </td>
      <td>
        <p>63</p>
      </td>
    </tr>
    <tr>
      <td>
        <p>Central Asia and Southern Asia </p>
      </td>
      <td>
        <p>86</p>
      </td>
      <td>
        <p>83</p>
      </td>
      <td>
        <p>45</p>
      </td>
      <td>
        <p>2</p>
      </td>
    </tr>
    <tr>
      <td>
        <p>Eastern Asia and South-eastern Asia </p>
      </td>
      <td>
        <p>84</p>
      </td>
      <td>
        <p>83</p>
      </td>
      <td>
        <p>14</p>
      </td>
      <td>
        <p>1</p>
      </td>
    </tr>
    <tr>
      <td>
        <p>Latin America &amp; the Caribbean </p>
      </td>
      <td>
        <p>75</p>
      </td>
      <td>
        <p>68</p>
      </td>
      <td>
        <p>70</p>
      </td>
      <td>
        <p>32</p>
      </td>
    </tr>
    <tr>
      <td>
        <p>Northern America and Europe </p>
      </td>
      <td>
        <p>93</p>
      </td>
      <td>
        <p>91</p>
      </td>
      <td>
        <p>80</p>
      </td>
      <td>
        <p>37</p>
      </td>
    </tr>
    <tr>
      <td>
        <p>Oceania </p>
      </td>
      <td>
        <p>70</p>
      </td>
      <td>
        <p>63</p>
      </td>
      <td>
        <p>70</p>
      </td>
      <td>
        <p>35</p>
      </td>
    </tr>
    <tr>
      <td>
        <p>Sub-Saharan Africa </p>
      </td>
      <td>
        <p>70</p>
      </td>
      <td>
        <p>40</p>
      </td>
      <td>
        <p>64</p>
      </td>
      <td>
        <p>20</p>
      </td>
    </tr>
    <tr>
      <td>
        <p>Western Asia and Northern Africa (M49) </p>
      </td>
      <td>
        <p>88</p>
      </td>
      <td>
        <p>83</p>
      </td>
      <td>
        <p>56</p>
      </td>
      <td>
        <p>1</p>
      </td>
    </tr>
  </tbody>
</table>
<p> </p>
<p><strong>Disaggregation:</strong></p>
<p>Geographical location, i.e. regional and national and potentially subnational estimates </p></div><a name="COMPARABILITY"></a><div id="COMPARABILITY"><p class="concept-name">6. Comparability/deviation from international standards</p><p><strong>Sources of discrepancies:</strong></p>
<p>Countries often relay on administrative coverage data, while WHO and UNICEF review and assess data from different sources including administrative systems and surveys. Differences between country produced and international estimates are mainly due to differences between coverage estimates from administrative system and survey results. </p>
<p> </p>
<p>In case the vaccine is not included in national immunization schedule the coverage from private sector vaccine delivery will not be reflected. </p></div><a name="OTHER_DOC"></a><div id="OTHER_DOC"><p class="concept-name">7. References and Documentation</p><p>Burton A, Monasch R, Lautenbach B, Gacic-Dobo M, Neill M, Karimov R, Wolfson L, Jones G, Birmingham M. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ. 2009;87(7):535-41.Available at: <a href="http://www.who.int/bulletin/volumes/87/7/08-053819/en/" target="_blank"><u>http://www.who.int/bulletin/volumes/87/7/08-053819/en/</u></a> </p>
<p> </p>
<p> Burton A, Kowalski R, Gacic-Dobo M, Karimov R, Brown D. A Formal Representation of the WHO and UNICEF Estimates of National Immunization Coverage: A Computational Logic Approach. PLoS ONE 2012;7(10): e47806. doi:10.1371/journal.pone.0047806. Available at: <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485034/pdf/pone.0047806.pdf" target="_blank"><u>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485034/pdf/pone.0047806.pdf</u></a> </p>
<p> </p>
<p>Brown D, Burton A, Gacic-Dobo M, Karimov R. An Introduction to the Grade of Confidence in the WHO and UNICEF Estimates of National Immunization Coverage. The Open Public Health Journal 2013, 6, 73-76. Available at: <a href="http://www.benthamscience.com/open/tophj/articles/V006/73TOPHJ.pdf" target="_blank"><u>http://www.benthamscience.com/open/tophj/articles/V006/73TOPHJ.pdf</u></a> </p>
<p> </p>
<p>Brown, David &amp; Burton, Anthony &amp; Gacic-Dobo, Marta. An examination of a recall bias adjustment applied to survey-based coverage estimates for multi-dose vaccines. 2015. 10.13140/RG.2.1.2086.2883. </p>
<p>Danovaro-Holliday MC, Gacic-Dobo M, Diallo MS <em>et al.</em> Compliance of WHO and UNICEF estimates of national immunization coverage (WUENIC) with Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) criteria. <em>Gates Open Res</em> 2021, 5:77 Available at: <a href="https://doi.org/10.12688/gatesopenres.13258.1">https://doi.org/10.12688/gatesopenres.13258.1</a></p></div>
        
      </section>

      <footer class="page__meta">
        
        


        


      </footer>

      

      
    </div>

    
  </article>

  
  
</div>

    </div>

    

    <div id="footer" class="page__footer">
      <footer>
        <!-- start custom footer snippets -->

<!-- end custom footer snippets -->
        <div class="page__footer-follow">
  <ul class="social-icons">
    
      <li><strong>Follow:</strong></li>
    

    
      
        
          <li><a href="https://www.worldbank.org/" rel="nofollow noopener noreferrer"><i class="fas fa-link" aria-hidden="true"></i> World Bank</a></li>
        
      
        
          <li><a href="https://www.worldbank.org/en/data/statistical-capacity-building/ecastat" rel="nofollow noopener noreferrer"><i class="fas fa-link" aria-hidden="true"></i> ECASTAT</a></li>
        
      
        
          <li><a href="https://github.com/worldbank/sdg-metadata" rel="nofollow noopener noreferrer"><i class="fab fa-fw fa-github" aria-hidden="true"></i> GitHub</a></li>
        
      
        
          <li><a href="https://www.worldbank.org/en/about/legal" rel="nofollow noopener noreferrer"><i class="fas fa-link" aria-hidden="true"></i> Legal</a></li>
        
      
    

    
  </ul>
</div>

<div class="page__footer-copyright">
  &copy; 2023 World Bank Group, all rights reserved.
</div>
      </footer>
    </div>

    
  
    <script src="/sdg-metadata/assets/js/main.min.js"></script>
  
    <script src="https://cdnjs.cloudflare.com/ajax/libs/jsPlumb/2.8.6/js/jsplumb.js"></script>
  
    <script src="https://unpkg.com/popper.js"></script>
  
    <script src="https://unpkg.com/tooltip.js"></script>
  
    <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.tablesorter/2.31.3/js/jquery.tablesorter.min.js"></script>
  
    <script src="/sdg-metadata/assets/js/custom.js"></script>
  










  </body>
</html>
